Professional Documents
Culture Documents
Cancer: Clinical Nutrition
Cancer: Clinical Nutrition
Clinical Nutrition
• Cure
• Control
• Palliate
Nutrient Need
• Energy
• 25-35kcal/kg
• Protein
• 1.2-2.0kal/kg when stressed
• Fluid
• 1-1.5ml/kg
• Micronutrients
• Standards MVI with mineral supplement may be needed due to poor PO intake
Alteration in protein metabolism
• Increase protein breakdown and decrease protein synthesis
• Cancer cachexia – progressive weight loss, poor appetite, muscle wasting,
immunosuppression.
• Caused by cytokines produces by the cancer cells or the immune system
• Pro-inflammatory cytokines – tumor necrosis factor alpha and beta, interleukin 1 and 6,
interferon
• Juven contains the amino acids glutamine and arginine in addition to beta-hydroxy-beta-
methylbutyrate (HMB). This agent may promote muscle protein synthesis and increase
muscle mass
Effect of loss of lean body mass
Loss of lean body mass Associated mortality
10% Decreased immunity 10%
Increased infections
20% Decreased healing, 30%
Weakness, infection
30% Too weak to sit, pressure ulcers , 50%
pneumonia
40% Death 100%
Effect of Juven
• Increase in weight and LBM
• https://touchoncology.com/wp-content/uploads/sites/2/2015/07/private_art
icles_1203_pdf_onco67371.pdf
Alteration in energy metabolism
• Tumor cells has a high demand for glucose and high rate of anaerobic
metabolism. Producing lactic acid
• Glucose intolerance/resistance
• Increased fat breakdown
• Overfeeding increase rate of cancer cells growth
Ketogenic diet
• https://www.sciencedirect.com/science/article/pii/S2212877819304272
• The ketogenic diet, a high-fat, low-carbohydrate diet with adequate
amounts of protein, appears to sensitize most cancers to standard
treatment
• Makeup of ketogenic diet varied in studies from 90% fat with 2%
carbohydrate to 70% fat 30% carbohydrate
• MCT oil increases absorption of fat and rate of ketone formation which
allows larger percentage of carbohydrate
Ketogenic diet cont’d
• In most preclinical studies, KD slowed tumor growth, prolonged the
survival rate, delayed the initiation of tumors, and reversed the process of
cancer-induced cachexia.
• 60% of the preclinical studies reported an antitumor effect of KDs, 17%
did not detect an influence on tumor growth and 10% reported adverse or
pro-proliferative effects.
• In multiple studies, the KD sensitized cancer cells to classic chemo- or
radiotherapies
Insulin and Cancer
• Insulin and/or IGF receptor signaling pathways contributes to
tumorigenesis
• A study including 9778 patients identified hyperinsulinemia as a risk
factor in cancer prognosis
• Clinical studies have demonstrated a reverse correlation between the level
of ketosis and the levels of glucose, insulin and/or IGF-1
Intermittent fasting
• Overnight fast of 14 hours or longer - reduction in recurrence for breast
cancer
• KD is good but long-term need to include plants for phytochemicals